-transparent.png){kind=logo}
Aplastic anemia is a rare but usually fatal complication of gold salt therapy for rheumatoid arthritis. This report describes 3 patients who developed aplastic anemia while receiving gold salts, and a fourth patient who developed aplastic anemia after receiving gold and then cytotoxic agents. These patients failed to respond to conventional therapy for aplastic anemia and subsequently received bone marrow transplants from HLA-matched siblings. Engraftment occurred in all 4 patients. One patient is alive 2 years after transplantation, and 3 patients died of complications following transplantation.
Related Publications
J L Baldwin, and
R Storb, and
E D Thomas, and
M Mannik
April 1985,
Australian and New Zealand journal of medicine,
J L Baldwin, and
R Storb, and
E D Thomas, and
M Mannik
January 1982,
Bulletin de la Societe des sciences medicales du Grand-Duche de Luxembourg,
J L Baldwin, and
R Storb, and
E D Thomas, and
M Mannik
June 1977,
Lancet (London, England),
J L Baldwin, and
R Storb, and
E D Thomas, and
M Mannik
July 1980,
Der Internist,
J L Baldwin, and
R Storb, and
E D Thomas, and
M Mannik
October 1978,
Revista brasileira de pesquisas medicas e biologicas,
J L Baldwin, and
R Storb, and
E D Thomas, and
M Mannik
November 1967,
The New England journal of medicine,
J L Baldwin, and
R Storb, and
E D Thomas, and
M Mannik
August 2009,
European journal of haematology,
J L Baldwin, and
R Storb, and
E D Thomas, and
M Mannik
March 1974,
British medical journal,
J L Baldwin, and
R Storb, and
E D Thomas, and
M Mannik
October 1977,
Haematologica,
J L Baldwin, and
R Storb, and
E D Thomas, and
M Mannik
June 1978,
Ginekologia polska,
